Cadila Healthcare
-
{
- All
- News
- Videos
-
Cadila Healthcare To Hive Off India Formulations Business
- Friday December 8, 2023
- Author: Press Trust of India
There will be no change in the shareholding pattern as business is transferred to a wholly owned subsidiary for cash consideration of Rs 69.3 crore, Cadila Healthcare said.
-
www.ndtvprofit.com
-
Cadila Healthcare To Hive Off India Formulations Business
- Friday December 8, 2023
- Author: Press Trust of India
There will be no change in the shareholding pattern as business is transferred to a wholly owned subsidiary for cash consideration of Rs 69.3 crore, Cadila Healthcare said.
-
www.ndtvprofit.com
-
Zydus Cadila Gets US Regulator's Nod To Sell Blood Pressure Drug
- Friday December 8, 2023
- Author: Press Trust of India
The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of filing process in FY2003-04, it added.
-
www.ndtvprofit.com
-
Cadila Healthcare Gets EIR From USFDA For Moraiya Facility
- Friday December 8, 2023
- Author: Press Trust of India
Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Moraiya, indicating "closure of the inspection points" of initial review in 2014.
-
www.ndtvprofit.com
-
Accumulate Cadila Healthcare; Buy Coal India: Pradip Hotchandani
- Friday December 8, 2023
- Author: NDTV Profit Team
Nifty is likely to go up to 8,655 as oscillators are strongly placed and investors should go long on Nifty with stop loss at 8,400, says Pradip Hotchandani, head of research at Prudent Broking Services.
-
www.ndtvprofit.com
-
Zydus To Sell Ulcerative Colitis Treatment Generic Drug In US Market
- Friday December 8, 2023
- Author: Press Trust of India
Drug firm Cadila Healthcare's US arm Zydus Pharmaceuticals (USA) Inc will start selling a generic version of Asacol HD, used for treatment of ulcerative colitis, in the American market from August 1, 2016.
-
www.ndtvprofit.com
-
Glenmark Pharma Seeks Foreign Partners on Biological Drugs
- Friday December 8, 2023
- Author: NDTV Profit Desk
Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.
-
www.ndtvprofit.com
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
- Friday December 8, 2023
- Author: NDTV Profit Desk
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
www.ndtvprofit.com
-
Cadila Healthcare Board Nod For Up To Fund Raising Up To Rs 18,500 Crore
- Friday December 8, 2023
- Author: Press Trust of India
Zydus Cadila group has global operations in four continents spread across the US, Europe, Latin America and South Africa and 25 other emerging markets.
-
www.ndtvprofit.com
-
Cadila Settles Patent Litigation Related To Livalo Tablets
- Friday December 8, 2023
- Author: Press Trust of India
Drug firm Cadila Healthcare has settled all outstanding patent litigation related to Livalo tablets with Kowa Company, Kowa Pharmaceuticals America Inc and Nissan Chemical Industries Ltd.
-
www.ndtvprofit.com
-
Cadila Healthcare Recalls Blood Pressure Drug in the US
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Headquartered in Ahmedabad, Zydus Cadila group has global operations in four continents spread across USA, Europe, Japan, Brazil, South Africa and 25 other emerging markets.
-
www.ndtvprofit.com
-
Cadila Healthcare Q1 Net Up 23.14 Per Cent at Rs 240.21 Crore
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Cadila Healthcare Ltd on Wednesday reported a 23.14 per cent increase in consolidated net profit at Rs 240.21 crore for the quarter ended June 30, 2014.
-
www.ndtvprofit.com
-
Cadila Healthcare Recovers after Falling 10%
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The US Food and Drug Administration's observation letter could result in approval delays at a time when the Cadila's domestic revenues have been impacted by price controls.
-
www.ndtvprofit.com
-
Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Potassium Citrate ER tablets in the strengths of 5 mEq, 10 mEq and 15 mEq, said the Zydus group's listed entity, Cadila Healthcare, said in a statement.
-
www.ndtvprofit.com
-
Cadila Healthcare To Hive Off India Formulations Business
- Friday December 8, 2023
- Author: Press Trust of India
There will be no change in the shareholding pattern as business is transferred to a wholly owned subsidiary for cash consideration of Rs 69.3 crore, Cadila Healthcare said.
-
www.ndtvprofit.com
-
Cadila Healthcare To Hive Off India Formulations Business
- Friday December 8, 2023
- Author: Press Trust of India
There will be no change in the shareholding pattern as business is transferred to a wholly owned subsidiary for cash consideration of Rs 69.3 crore, Cadila Healthcare said.
-
www.ndtvprofit.com
-
Zydus Cadila Gets US Regulator's Nod To Sell Blood Pressure Drug
- Friday December 8, 2023
- Author: Press Trust of India
The group has now more than 150 approvals and has so far filed over 300 abbreviated new drug applications (ANDAs) since the commencement of filing process in FY2003-04, it added.
-
www.ndtvprofit.com
-
Cadila Healthcare Gets EIR From USFDA For Moraiya Facility
- Friday December 8, 2023
- Author: Press Trust of India
Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Moraiya, indicating "closure of the inspection points" of initial review in 2014.
-
www.ndtvprofit.com
-
Accumulate Cadila Healthcare; Buy Coal India: Pradip Hotchandani
- Friday December 8, 2023
- Author: NDTV Profit Team
Nifty is likely to go up to 8,655 as oscillators are strongly placed and investors should go long on Nifty with stop loss at 8,400, says Pradip Hotchandani, head of research at Prudent Broking Services.
-
www.ndtvprofit.com
-
Zydus To Sell Ulcerative Colitis Treatment Generic Drug In US Market
- Friday December 8, 2023
- Author: Press Trust of India
Drug firm Cadila Healthcare's US arm Zydus Pharmaceuticals (USA) Inc will start selling a generic version of Asacol HD, used for treatment of ulcerative colitis, in the American market from August 1, 2016.
-
www.ndtvprofit.com
-
Glenmark Pharma Seeks Foreign Partners on Biological Drugs
- Friday December 8, 2023
- Author: NDTV Profit Desk
Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.
-
www.ndtvprofit.com
-
Top 5 Pharma Companies Lose 19,000 Crore In Market Value. Here Is Why
- Friday December 8, 2023
- Author: NDTV Profit Desk
Analysts say the fresh selloff in the pharmaceutical shares has been triggered after Sun Pharma's US-based subsidiary Taro Pharmaceuticals reported a weak set of earnings in the March quarter.
-
www.ndtvprofit.com
-
Cadila Healthcare Board Nod For Up To Fund Raising Up To Rs 18,500 Crore
- Friday December 8, 2023
- Author: Press Trust of India
Zydus Cadila group has global operations in four continents spread across the US, Europe, Latin America and South Africa and 25 other emerging markets.
-
www.ndtvprofit.com
-
Cadila Settles Patent Litigation Related To Livalo Tablets
- Friday December 8, 2023
- Author: Press Trust of India
Drug firm Cadila Healthcare has settled all outstanding patent litigation related to Livalo tablets with Kowa Company, Kowa Pharmaceuticals America Inc and Nissan Chemical Industries Ltd.
-
www.ndtvprofit.com
-
Cadila Healthcare Recalls Blood Pressure Drug in the US
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Headquartered in Ahmedabad, Zydus Cadila group has global operations in four continents spread across USA, Europe, Japan, Brazil, South Africa and 25 other emerging markets.
-
www.ndtvprofit.com
-
Cadila Healthcare Q1 Net Up 23.14 Per Cent at Rs 240.21 Crore
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Cadila Healthcare Ltd on Wednesday reported a 23.14 per cent increase in consolidated net profit at Rs 240.21 crore for the quarter ended June 30, 2014.
-
www.ndtvprofit.com
-
Cadila Healthcare Recovers after Falling 10%
- Thursday December 7, 2023
- Author: NDTV Profit Desk
The US Food and Drug Administration's observation letter could result in approval delays at a time when the Cadila's domestic revenues have been impacted by price controls.
-
www.ndtvprofit.com
-
Zydus Cadila Gets USFDA Nod for Kidney Stones Tablets
- Thursday December 7, 2023
- Author: NDTV Profit Desk
Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Potassium Citrate ER tablets in the strengths of 5 mEq, 10 mEq and 15 mEq, said the Zydus group's listed entity, Cadila Healthcare, said in a statement.
-
www.ndtvprofit.com